Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 385

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 385
---
ings (as defined in the Fifth Securities Purchase Agreement) by an offsetting amount. There was no change to the aggregate amount of up to $ 7million of proceeds to be funded pursuant to the Fifth Securities Purchase Agreement upon consummation of all of the Closings (as defined in the Fifth Securities Purchase Agreement) provided for therein. On October 16, 2025, pursuant to the Fifth Securities Purchase Agreement, the Company issued and sold, and certain investors purchased 3,816shares of the Series E Preferred Stock for aggregate proceeds of approximately $ 2.25million, paid in cash. Each Additional Closing under the Fifth Securities Purchase Agreement is subject to a mutual option of the Company and certain investors and satisfaction of customary closing conditions. F-31

The Fifth Securities Purchase
Agreement includes the consent of the holders of the Company’s outstanding Series C and Series D Preferred Stock to the issuance
of the Series E Preferred Stock pari passu therewith, in consideration for the reduction of the conversion price for the Company’s
outstanding Series C and Series D convertible preferred stock to $, effective as of the date of the Fifth Securities Purchase Agreement.

On October 14, 2025, the Company filed the Certificate
of Designations of Rights and Preferences of the Series E Preferred Stock (the “Series E Certificate of Designations”) establishing
and designating shares of the Company’s Series E Preferred Stock and establishing the rights, preferences and privileges
of the Series E Preferred Stock, as summarized below:

General. Each share
of Series E Preferred Stock has a stated value of $ per share and, when issued, the Series E Preferred Stock will be fully paid and
non-assessable.

Ranking. The Series
E Preferred Stock, with respect to the payment of dividends, distributions and payments upon the liquidation, dissolution and winding
up of the Company, ranks senior to all capital stock of the Company (except the Series A convertible preferred stock which will rank senior
to the Series E Preferred Stock and except for the Series C convertible preferred stock and Series D convertible preferred stock, which
will rank pari passu to the Series E Preferred Stock) unless the Required Holders (as defined in the Fifth Securities Purchase
Agreement) consent to the creation of other capital stock of the Company that is senior or equal in rank to the Series E Preferred Stock.

Dividends. The holders
of Series E Preferred Stock will be entitled to dividends, on an as-if converted basis, equal to and in the same